Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrillation
Latest Information Update: 04 Jan 2024
At a glance
- Drugs Beta adrenergic receptor antagonists (Primary) ; Landiolol (Primary) ; Antiarrhythmics; Beta adrenergic receptor antagonists; Digoxin
- Indications Decompensated heart failure
- Focus Therapeutic Use
- Acronyms LARISA
- 07 Jan 2021 New trial record